About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Tectonic Therapeutic Strengthens Leadership Team

Tectonic Therapeutic, Inc. a pre-clinical stage biotechnology company transforming the discovery of novel GPCR-targeted therapies (G-Protein Coupled Receptors), today announced the promotion of Senior Vice President, Head of Research, Peter McNamara, PhD, to Chief Scientific Officer as well as the appointments of Barry Rubenstein as Senior Vice President, People and Culture and Washington Alves as Vice President, Biologics Manufacturing.

“Since joining our leadership team just a year ago, Peter has played an instrumental role in building an exceptional research organization that achieved validation of our discovery platform. This well-deserved promotion recognizes his outstanding work and leadership as we transition to the next phase of Tectonic’s growth,” said Alise Reicin, MD, President and Chief Executive Officer, Tectonic Therapeutic.

Dr. McNamara joined Tectonic in May 2021 as Senior Vice President, Head of Research. Prior to joining, Dr. McNamara was Head of Biotherapeutics and Biotechnology at the Genomics Institute of the Novartis Research Foundation (GNF), where he was responsible for GNF’s platform technologies in biotherapeutics discovery and optimization, protein sciences, structural biology, functional genomics, high throughput screening, automation and engineering. Dr. McNamara also served as Executive Director, Head of General Medical Biology at GNF where he was responsible for the scientific strategies and drug discovery activities pertaining to GNF’s programs across a broad range of disease areas with special emphasis on regenerative medicine and tissue repair. Dr. McNamara earned his PhD and BSc in Biochemistry from the National University of Ireland at Galway and was a post-doctoral Fellow at the University of Pennsylvania where he became a member of the Faculty at the Institute for Translational Medicine and Therapeutics in the School of Medicine.

“Tectonic has significantly expanded its team over the past year. I am excited to welcome Barry who will lead our HR department and help foster the collaborative environment we thrive on,” added Dr. Reicin. “Additionally, Washington’s leadership and expertise in GMP manufacturing will be invaluable as we advance our GPCR-targeting candidates into development.”

Mr. Rubenstein has over 20 years of HR experience in the biotechnology sector. Prior to joining Tectonic, Mr. Rubenstein led HR at Kala Therapeutics where he was VP, Human Resources and head of the department. Prior to Kala, Mr. Rubenstein was at AMAG Pharmaceuticals for 9 years, where he rose to the position of Executive Director of HR. He has broad experience in HR, which includes Executive Coaching, Leadership Training, Benefits, Talent Acquisition, Performance Management, Organizational Design, Compensation and Career Development. Mr. Rubenstein holds a BS in Psychology from Boston University and a Master of Science, Business Administration from Nova Southeastern University.

Mr. Alves brings over 20 years of biologics manufacturing and process development experience. Before joining Tectonic, Mr. Alves served as Senior Director, CMC Operations at Gemini Therapeutics where he led technical operations and CMC strategy. He started his career at Pfizer (former Genetics Institute) in commercial manufacturing where he worked on the manufacturing of RECOMBINATE® (recombinant Factor VIII) and then spent several years at Merrimack Pharmaceuticals where he established mammalian expression capabilities, designed and built clinical manufacturing plants, and managed tech transfer and manufacturing of multiple products into production, delivering 170 batches of material to support clinical development. Mr. Alves has a BS in Chemical Engineering from University of Massachusetts, Lowell and a Master of Science in Engineering Management from Tufts.

About Tectonic Therapeutic

Tectonic, co-founded by Andrew Kruse and Tim Springer of Harvard Medical School, is transforming the discovery of antibodies and other biologic drugs targeting G-Protein Coupled Receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. With our proprietary GEODe platform, we aim to unlock the therapeutic utility of the most difficult receptors in the class, to date considered undruggable with small molecules. For more information, please visit www.tectonictx.com, or follow us on LinkedIn.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.